BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10348751)

  • 1. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase.
    Wu SW; Dornbusch K; Kronvall G; Norgren M
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1350-7. PubMed ID: 10348751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance.
    Bauernfeind A; Stemplinger I; Jungwirth R; Giamarellou H
    Antimicrob Agents Chemother; 1996 Jan; 40(1):221-4. PubMed ID: 8787910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta-lactamase genes.
    Bauernfeind A; Stemplinger I; Jungwirth R; Wilhelm R; Chong Y
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1926-30. PubMed ID: 8843306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.
    Ahmed AM; Shimamoto T
    Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
    Zioga A; Whichard JM; Kotsakis SD; Tzouvelekis LS; Tzelepi E; Miriagou V
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1256-9. PubMed ID: 19104021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis.
    Verdet C; Arlet G; Ben Redjeb S; Ben Hassen A; Lagrange PH; Philippon A
    FEMS Microbiol Lett; 1998 Dec; 169(2):235-40. PubMed ID: 9868767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible expression of the chromosomal cdiA from Citrobacter diversus NF85, encoding an ambler class A beta-lactamase, is under similar genetic control to the chromosomal ampC, encoding an ambler class C enzyme, from Citrobacter freundii OS60.
    Jones ME; Bennett PM
    Microb Drug Resist; 1995; 1(4):285-91. PubMed ID: 9158798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFE-1, a novel plasmid-encoded AmpC beta-lactamase with an ampR gene originating from Citrobacter freundii.
    Nakano R; Okamoto R; Nakano Y; Kaneko K; Okitsu N; Hosaka Y; Inoue M
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1151-8. PubMed ID: 15047515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CFE-2, a new plasmid-encoded AmpC β-lactamase from a clinical isolate of Citrobacter freundii.
    Chen CM; Huang M; Wu HJ; Guo MK; Wu LT
    Int J Antimicrob Agents; 2018 Sep; 52(3):421-424. PubMed ID: 29944954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to gram-negative organisms due to high-level expression of plasmid-encoded ampC beta-lactamase blaCMY-4 promoted by insertion sequence ISEcp1.
    Nakano R; Okamoto R; Nagano N; Inoue M
    J Infect Chemother; 2007 Feb; 13(1):18-23. PubMed ID: 17334724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMY-20, a novel AmpC-type beta-lactamase from South African clinical Escherichia coli isolates.
    Mocktar C; Govinden U; Sturm AW; Essack SY
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):405-8. PubMed ID: 18207348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-Specific Patterns of Genetic Diversity among IncI1-Iγ and IncK Plasmids Encoding CMY-2 β-Lactamase in Escherichia coli Isolates from Humans, Poultry Meat, Poultry, and Dogs in Denmark.
    Hansen KH; Bortolaia V; Nielsen CA; Nielsen JB; Schønning K; Agersø Y; Guardabassi L
    Appl Environ Microbiol; 2016 Aug; 82(15):4705-14. PubMed ID: 27235431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of a plasmid mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isolate.
    Pörnull KJ; Rodrigo G; Dornbusch K
    J Antimicrob Chemother; 1994 Dec; 34(6):943-54. PubMed ID: 7730237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of WGS data for investigation of a long-term NDM-1-producing Citrobacter freundii outbreak and secondary in vivo spread of blaNDM-1 to Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Hammerum AM; Hansen F; Nielsen HL; Jakobsen L; Stegger M; Andersen PS; Jensen P; Nielsen TK; Hansen LH; Hasman H; Fuglsang-Damgaard D
    J Antimicrob Chemother; 2016 Nov; 71(11):3117-3124. PubMed ID: 27494919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel CMY-2-type β-lactamases encountered in clinical Escherichia coli isolates.
    Manageiro V; Ferreira E; Pinto M; Fonseca F; Ferreira M; Bonnet R; Caniça M
    Ann Clin Microbiol Antimicrob; 2015 Mar; 14():12. PubMed ID: 25885413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics.
    Arakawa Y; Ohta M; Kido N; Mori M; Ito H; Komatsu T; Fujii Y; Kato N
    Antimicrob Agents Chemother; 1989 Jan; 33(1):63-70. PubMed ID: 2653216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Beta-lactamases in Faecal Enterobacteriaceae Recovered from Healthy Humans in Spain: Focusing on AmpC Polymorphisms.
    Porres-Osante N; Sáenz Y; Somalo S; Torres C
    Microb Ecol; 2015 Jul; 70(1):132-40. PubMed ID: 25501887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.
    Literacka E; Empel J; Baraniak A; Sadowy E; Hryniewicz W; Gniadkowski M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4136-43. PubMed ID: 15504832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.
    Gazouli M; Tzouvelekis LS; Vatopoulos AC; Tzelepi E
    J Antimicrob Chemother; 1998 Oct; 42(4):419-25. PubMed ID: 9818739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.